1. Home
  2. SQNS vs INMB Comparison

SQNS vs INMB Comparison

Compare SQNS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$4.05

Market Cap

48.0M

Sector

Technology

ML Signal

HOLD

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$1.57

Market Cap

40.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
INMB
Founded
2003
2015
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.0M
40.4M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
SQNS
INMB
Price
$4.05
$1.57
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$20.33
$5.40
AVG Volume (30 Days)
285.6K
364.9K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.85
EPS
N/A
N/A
Revenue
N/A
$50,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$49.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
257.14
52 Week Low
$0.73
$1.09
52 Week High
$10.93
$11.64

Technical Indicators

Market Signals
Indicator
SQNS
INMB
Relative Strength Index (RSI) 67.73 57.51
Support Level $2.55 $1.38
Resistance Level $6.88 $1.71
Average True Range (ATR) 0.34 0.11
MACD 0.08 0.01
Stochastic Oscillator 81.52 54.17

Price Performance

Historical Comparison
SQNS
INMB

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: